NIH launches initiative to speed rapid COVID-19 testing

Apr 29, 2020 - 04:02 PM
COVID19 Testing Web Sized

The National Institutes of Health today urged scientists and inventors with a rapid testing technology to compete for a share of $500 million in funding to develop accurate at-home and point-of-care diagnostic tests, with the goal to make millions of tests available per week by the end of summer and even more in time for the flu season.

“We need American tech experts, innovators and entrepreneurs to step up to one of the toughest challenges we’ve faced as a country, to help get us safely back to public spaces,” said Bruce Tromberg, director of the National Institute of Biomedical Imaging and Bioengineering.

The challenge is part of a new NIH Rapid Acceleration of Diagnostics (RADx) initiative that will invest $1.5 billion in funding from the Paycheck Protection Program and Health Care Enhancement Act in early innovative testing technologies. RADx will expand an NIBIB Point-of-Care Technologies Research Network that supports innovators through technology hubs at Emory University/Georgia Institute of Technology; Johns Hopkins University; Northwestern University; University of Massachusetts Medical School; and the Consortia for Improving Medicine with Innovation & Technology at Harvard Medical School/Massachusetts General Hospital.

Related News Articles

Headline
CDC releases 2025-26 respiratory disease season outlook
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
OSHA extends comment period on proposal removing remaining COVID-19 emergency temporary standard requirements
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…
Headline
CDC says COVID-19 cases growing or likely growing in 45 states 
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
FDA announces recall of cefazolin by Sandoz for mislabeling
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
COVID-19 vaccination approved for older adults and high-risk, younger children
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
OSHA proposes removing remaining requirements of its COVID-19 emergency temporary standard
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational…